174 related articles for article (PubMed ID: 36056234)
1. Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate.
van der Pol KH; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Guchelaar HJ; Risselada A; van Schaik RHN; Swen JJ; Touw D; van der Weide J; van Westrhenen R; Deneer VHM; Houwink EJF; Rongen GA
Eur J Hum Genet; 2024 Feb; 32(2):155-162. PubMed ID: 36056234
[TBL] [Abstract][Full Text] [Related]
2. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs.
Manson LEN; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Houwink EJF; Risselada A; Rongen GAPJM; van Schaik RHN; Swen JJ; Touw DJ; van Westrhenen R; Deneer VHM; Guchelaar HJ
Eur J Hum Genet; 2024 Apr; ():. PubMed ID: 38570725
[TBL] [Abstract][Full Text] [Related]
3. Understanding the impact of ABCG2 polymorphisms on drug pharmacokinetics: focus on rosuvastatin and allopurinol.
Kasten A; Cascorbi I
Expert Opin Drug Metab Toxicol; 2024 Jun; 20(6):519-528. PubMed ID: 38809523
[TBL] [Abstract][Full Text] [Related]
4. Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.
Hulshof EC; Deenen MJ; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Houwink EJF; Risselada A; Rongen GAPJM; van Schaik RHN; Touw DJ; van der Weide J; van Westrhenen R; Deneer VHM; Guchelaar HJ; Swen JJ
Eur J Hum Genet; 2023 Sep; 31(9):982-987. PubMed ID: 36443464
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions.
Ke CH; Chung WH; Wen YH; Huang YB; Chuang HY; Tain YL; Wang YL; Wu CC; Hsu CN
J Rheumatol; 2017 Jun; 44(6):835-843. PubMed ID: 28365572
[TBL] [Abstract][Full Text] [Related]
6. Association of single nucleotide polymorphisms in MTHFR and ABCG2 with the different efficacy of first-line chemotherapy in metastatic colorectal cancer.
Zhao J; Li W; Zhu D; Yu Q; Zhang Z; Sun M; Cai S; Zhang W
Med Oncol; 2014 Jan; 31(1):802. PubMed ID: 24338217
[TBL] [Abstract][Full Text] [Related]
7. Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate.
Nijenhuis M; Soree B; Jama WOM; de Boer-Veger NJ; Buunk AM; Guchelaar HJ; Houwink EJF; Rongen GA; van Schaik RHN; Swen JJ; Touw D; van der Weide J; van Westrhenen R; Deneer VHM; Risselada A
Eur J Hum Genet; 2023 Dec; 31(12):1364-1370. PubMed ID: 36509836
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout.
Plumpton CO; Alfirevic A; Pirmohamed M; Hughes DA
Rheumatology (Oxford); 2017 Oct; 56(10):1729-1739. PubMed ID: 28957559
[TBL] [Abstract][Full Text] [Related]
9. ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout.
Roberts RL; Wallace MC; Phipps-Green AJ; Topless R; Drake JM; Tan P; Dalbeth N; Merriman TR; Stamp LK
Pharmacogenomics J; 2017 Mar; 17(2):201-203. PubMed ID: 26810134
[TBL] [Abstract][Full Text] [Related]
10. ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population.
Zhang K; Li C
Hereditas; 2019; 156():26. PubMed ID: 31367212
[TBL] [Abstract][Full Text] [Related]
11. The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool.
Wright DFB; Dalbeth N; Phipps-Green AJ; Merriman TR; Barclay ML; Drake J; Tan P; Horne A; Stamp LK
Br J Clin Pharmacol; 2018 May; 84(5):937-943. PubMed ID: 29341237
[TBL] [Abstract][Full Text] [Related]
12. Is HLA-B*58:01 genotyping cost effective in guiding allopurinol use in gout patients with chronic kidney disease?
Teng GG; Tan-Koi WC; Dong D; Sung C
Pharmacogenomics; 2020 Mar; 21(4):279-291. PubMed ID: 32180492
[No Abstract] [Full Text] [Related]
13. Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.
Wu R; Cheng YJ; Zhu LL; Yu L; Zhao XK; Jia M; Wen CH; Long XZ; Tang T; He AJ; Zeng YY; Ma ZF; Zheng Z; Ni MZ; Cai GJ
Oncotarget; 2016 Dec; 7(49):81870-81879. PubMed ID: 27835909
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of sequential urate lowering therapies for the management of gout in Singapore.
Pruis SL; Jeon YK; Pearce F; Thong BY; Aziz MIA
J Med Econ; 2020 Aug; 23(8):838-847. PubMed ID: 32301360
[No Abstract] [Full Text] [Related]
15. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
Yeo SI
Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore.
Dong D; Tan-Koi WC; Teng GG; Finkelstein E; Sung C
Pharmacogenomics; 2015 Nov; 16(16):1781-93. PubMed ID: 26554739
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.
Zajc Avramovič M; Dolžan V; Toplak N; Accetto M; Lusa L; Avčin T
J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
Wen CC; Yee SW; Liang X; Hoffmann TJ; Kvale MN; Banda Y; Jorgenson E; Schaefer C; Risch N; Giacomini KM
Clin Pharmacol Ther; 2015 May; 97(5):518-25. PubMed ID: 25676789
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study.
Yu KH; Lai JH; Hsu PN; Chen DY; Chen CJ; Lin HY
Scand J Rheumatol; 2016 Jul; 45(4):304-11. PubMed ID: 26771445
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
